References
- HonboTKobayashiMHaneKHataTUedaYThe oral dosage form of FK-506Transplant Proc1987195 suppl 6S17S22
- HanifinJMLingMRLangleyRBrenemaDRafalETacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacyJ Am Acad Dermatol2001441 supplS28S3811145793
- WollenbergAReitamoSAtzoriFProactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointmentAllergy2008636742750
- EzquerraGMReganaMSAcostaEHMilletPUTopical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaquesJ Drugs Dermatol20065433433616673800
- LauermaAISteinBDHomeyBLeeCHBloomEMaibachHITopical FK506: suppression of allergic and irritant contact dermatitis in the guinea pigArch Dermatol Res199428663373407526805
- GoebelASNeubertRHWohlrabJDermal targeting of tacrolimus using colloidal carrier systemsInt J Pharm20114041–215916821094231
- YamanakaMYokotaSIwaoYNoguchiSItaiSDevelopment and evaluation of a tacrolimus cream formulation using a binary solvent systemInt J Pharm20144641–2192624456671
- LiGFanYFanCTacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluationEur J Pharm Biopharm2012821495722705640
- PoplePVSinghKKTargeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitisInt J Pharm20103981–216517820637847
- PoplePVSinghKKDevelopment and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimusEur J Pharm Biopharm2011791829421447390
- GomesMJMartinsSFerreiraDSegundoMAResisSLipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studiesInt J Nanomedicine201491231124224634584
- FilonFLMauroMAdamiGBovenziMCroseraMNanoparticles skin absorption: new aspects for a safety profile evaluationRegul Toxicol Pharmacol201572231032225979643
- TryCMoulariBBéduneauASize dependent skin penetration of nanoparticles in murine and porcine dermatitis modelsEur J Pharm Biopharm201610010110826792104
- WeissmannBMeyerKThe structure of hyalobiuronic acid and of hyaluronic acid from umbilical Cord1, 2J Am Chem Soc195476717531757
- BalazsEATherapeutic use of hyaluronanStruct Chem2009202341349
- GaffneyJMatou-NasriSGrau-OlivaresMSlevinMTherapeutic applications of hyaluronanMol Biosyst20106343744320174672
- BrownMBJonesSAHyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skinJ Eur Acad Dermatol Venereol200519330831815857456
- MooreARWilloughbyDAHyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of actionInt J Tissue React19951741531568867645
- BrownTJAlcornDFraserJRAbsorption of hyaluronan applied to the surface of intact skinJ Invest Dermatol1999113574074610571728
- WangCTammiMTammiRDistribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendagesHistochemistry19929821051121429018
- TammiRSäämänenAMMaibachHITammiMDegradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ cultureJ Invest Dermatol19919711261302056182
- TripodoGTrapaniATorreMLGiammonaGTrapaniGMandracchiaDHyaluronic acid and its derivatives in drug delivery and imaging: recent advances and challengesEur J Pharm Biopharm201597pt B40041626614559
- ChoiKYChungHMinKHSelf-assembled hyaluronic acid nanoparticles for active tumor targetingBiomaterials201031110611419783037
- ChoiKMJangMKimJHAhnHJTumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexesBiomaterials201435257121713224854094
- SongSQiHXuJHyaluronan-based nanocarriers with CD44-overexpressed cancer cell targetingPharm Res201431112988300524842660
- KooHMinKHLeeSCEnhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel deliveryJ Control Release2013172382383124035978
- RasoolAAHussainAADittertLWSolubility enhancement of some water–insoluble drugs in the presence of nicotinamide and related compoundsJ Pharm Sci19918043873931830901
- LimLYGoMLCaffeine and nicotinamide enhances the aqueous solubility of the antimalarial agent halofantrineEur J Pharm Sci2000101172810699380
- HuangYZhangBGaoYZhangJShiLBaicalein–nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailabilityJ Pharm Sci201410382330233724903146
- FanXChenJShenQDocetaxel–nicotinamide complex-loaded nanostructured lipid carriers for transdermal deliveryInt J Pharm2013458229630424177313
- VirágLSzabóCThe therapeutic potential of poly(ADP-ribose) polymerase inhibitorsPharmacol Rev200254337542912223530
- NamaziMRNicotinamide as a potential addition to the anti-atopic dermatitis armamentariumInt Immunopharmacol20044670971215135312
- NirenNMPharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a reviewCutis2006771 suppl111616871774
- LevineDEven-ChenZLipetsIPilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasisJ Am Acad Dermatol201063577578120599292
- BardBMartelSCarruptPAHigh throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant mediaEur J Pharm Sci200833323024018207706
- CheJWuZShaoWSynergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazoleEur J Pharm Biopharm20159313614825845772
- NicoliSZaniFBilziSBettiniRSantiPAssociation of nicotinamide with parabens: effect on solubility, partition and transdermal permeationEur J Pharm Biopharm200869261362118207718
- CoffmanREKildsigDOEffect of nicotinamide and urea on the solubility of riboflavin in various solventsJ Pharm Sci19968599519548877885
- SanghviREvansDYalkowskySHStacking complexation by nicotinamide: a useful way of enhancing drug solubilityInt J Pharm20073361354117145146
- SuzukiHSunadaHMechanistic studies on hydrotropic solubilization of nifedipine in nicotinamide solutionChem Pharm Bull (Tokyo)19984611251309468644
- CuiYXingCRanYMolecular dynamics simulations of hydrotropic solubilization and self-aggregation of nicotinamideJ Pharm Sci20109973048305920112429
- ZhangYZhangKWuZEvaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake IInt J Pharm2015478113814625448576
- Alvarez-RománRNaikAKaliaYNGuyRHFessiHSkin penetration and distribution of polymeric nanoparticlesJ Control Release2004991536215342180
- JenningVGyslerASchäfer-KortingMGohlaSHVitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skinEur J Pharm Biopharm200049321121810799811
- CampbellCSContreras-RojasLRDelgado-CharroMBGuyRHObjective assessment of nanoparticle disposition in mammalian skin after topical exposureJ Control Release2012162120120722732479
- BoakyeCHPatelKSinghMDoxorubicin liposomes as an investigative model to study the skin permeation of nanocarriersInt J Pharm20154891–210611625910414
- XingJDengLLiJAmphiphilic poly {[-maleic anhydride-ω-methoxy-poly (ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug deliveryInt J Nanomedicine2009422723219918369
- LademannJKnorrFRichterHHair follicles–an efficient storage and penetration pathway for topically applied substancesSkin Pharmacol Physiol200821315015518523412
- PoplePVSinghKKTargeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-part II: in vivo assessment of dermatopharmacokinetics, biodistribution and efficacyInt J Pharm20124341–2707922609427
- PoplePVSinghKKDevelopment and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, part II–In vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitisEur J Pharm Biopharm2013841728323246619
- RancanFGaoQGrafCSkin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stabilityACS Nano2012686829684222797484
- MuCFBalakrishnanPCuiFDThe effects of mixed MPEG–PLA/Pluronic® copolymer micelles on the bioavailability and multidrug resistance of docetaxelBiomaterials20103182371237920031202
- DongYFengSSIn vitro and in vivo evaluation of methoxy polyethylene glycol–polylactide (MPEG–PLA) nanoparticles for small-molecule drug chemotherapyBiomaterials200728284154416017576004
- LiXChenDLeCNovel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptakeInt J Nanomedicine201163151316222163166
- ZhouJHaggertyJGMilstoneLMGrowth and differentiation regulate CD44 expression on human keratinocytesIn Vitro Cell Dev Biol Anim199935422823510478803